Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intratumoral Bleomycin for Supratentorial Glioblastoma
NCT00006916Phase 2Terminated
- Sponsor
- NRG Oncology
- Start
- Jun 2001
- Primary completion
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bleomycin in glioblastoma multiforme (GBM), sponsored by NRG Oncology. Started Jun 2001; status: terminated.
02
Drugs
bleomycin
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00006916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006916.